The launch of Sarah Cannon Research UK and research developments at ASCO 2010
22 Jul 2010
The launch of Sarah Cannon Research UK and research developments at ASCO 2010
Key advances in ovarian cancer from ASCO 2010
Systemic therapy - what lies ahead?
Ovarian cancer research
Prognostic and predictive markers in breast cancer
Targeted therapy in sarcoma treatment
ALK mutation related non-small cell lung cancer
The PRIMA study
An immunotherapy approach to pancreatic cancer
Biotherapy Development Association
PARP inhibitors
Advances in melanoma treatment